JP2025511899A5 - - Google Patents
Info
- Publication number
- JP2025511899A5 JP2025511899A5 JP2024559484A JP2024559484A JP2025511899A5 JP 2025511899 A5 JP2025511899 A5 JP 2025511899A5 JP 2024559484 A JP2024559484 A JP 2024559484A JP 2024559484 A JP2024559484 A JP 2024559484A JP 2025511899 A5 JP2025511899 A5 JP 2025511899A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263362501P | 2022-04-05 | 2022-04-05 | |
| US63/362,501 | 2022-04-05 | ||
| US202263366462P | 2022-06-15 | 2022-06-15 | |
| US63/366,462 | 2022-06-15 | ||
| US202363489381P | 2023-03-09 | 2023-03-09 | |
| US63/489,381 | 2023-03-09 | ||
| PCT/US2023/017647 WO2023196444A1 (en) | 2022-04-05 | 2023-04-05 | Ionizable cationic lipids and lipid nanoparticles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511899A JP2025511899A (ja) | 2025-04-16 |
| JP2025511899A5 true JP2025511899A5 (enExample) | 2026-04-15 |
Family
ID=88240397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559484A Pending JP2025511899A (ja) | 2022-04-05 | 2023-04-05 | イオン化可能なカチオン性脂質および脂質ナノ粒子 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20230320995A1 (enExample) |
| EP (1) | EP4504694A4 (enExample) |
| JP (1) | JP2025511899A (enExample) |
| KR (1) | KR20250009428A (enExample) |
| CN (1) | CN119013250A (enExample) |
| AU (1) | AU2023249179A1 (enExample) |
| CA (1) | CA3254658A1 (enExample) |
| IL (1) | IL315577A (enExample) |
| MX (1) | MX2024012161A (enExample) |
| WO (1) | WO2023196444A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024192291A1 (en) | 2023-03-15 | 2024-09-19 | Renagade Therapeutics Management Inc. | Delivery of gene editing systems and methods of use thereof |
| EP4680595A2 (en) | 2023-03-15 | 2026-01-21 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| EP4719352A1 (en) * | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025006799A1 (en) | 2023-06-27 | 2025-01-02 | Capstan Therapeutics, Inc. | Extracorporeal and ex vivo engineering of select cell populations from peripheral blood |
| US20250127728A1 (en) * | 2023-10-05 | 2025-04-24 | Capstan Therapeutics, Inc. | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| US20250144234A1 (en) | 2023-11-02 | 2025-05-08 | Capstan Therapeutics Inc. | RNA for In vivo Transfection with Increased Expression |
| CN122228239A (zh) * | 2023-11-15 | 2026-06-16 | 上海尧唐生物科技股份有限公司 | 递送治疗剂的脂质化合物及其制备方法与应用 |
| CN117263882B (zh) * | 2023-11-21 | 2024-02-23 | 深圳瑞吉生物科技有限公司 | 一种阳离子脂质化合物、包含其的组合物及应用 |
| WO2025128871A2 (en) | 2023-12-13 | 2025-06-19 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| IL328626A (en) | 2023-12-15 | 2026-07-01 | Capstan Therapeutics Inc | Humanized anti-CD8 antibodies and their uses |
| WO2025155753A2 (en) | 2024-01-17 | 2025-07-24 | Renagade Therapeutics Management Inc. | Improved gene editing system, guides, and methods |
| WO2025166238A1 (en) | 2024-01-31 | 2025-08-07 | Orna Therapeutics, Inc. | Fast-shedding polyethylene glycol lipids |
| WO2025174765A1 (en) | 2024-02-12 | 2025-08-21 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| US20250302763A1 (en) | 2024-02-22 | 2025-10-02 | Capstan Therapeutics, Inc. | Immune engineering amplification |
| WO2025180454A1 (zh) * | 2024-02-28 | 2025-09-04 | 成都凌泰氪生物技术有限公司 | 一种亲脂性化合物、其制备方法及应用 |
| US20250381150A1 (en) | 2024-03-08 | 2025-12-18 | Genzyme Corporation | Lipid nanoparticles |
| WO2025217452A1 (en) * | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) * | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
| WO2025232898A1 (en) * | 2024-05-10 | 2025-11-13 | Yoltech Therapeutics Co., Ltd | Lipid compounds and lipid nanoparticle compositions |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| WO2026030375A2 (en) | 2024-07-30 | 2026-02-05 | Genzyme Corporation | Lipid nanoparticles and methods of manufacture and use thereof |
| WO2026122685A1 (en) | 2024-12-03 | 2026-06-11 | Orna Therapeutics, Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| WO2026142951A1 (en) | 2024-12-23 | 2026-07-02 | Genzyme Corporation | Pharmaceutical system |
| WO2026165530A1 (en) | 2025-02-03 | 2026-08-06 | Renagade Therapeutics Management Inc. | Hydrophilic polymer lipids for use in lipid nanoparticles |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2223088A1 (en) * | 1995-06-07 | 1996-12-19 | Bob Dale Brown | Novel carbamate-based cationic lipids |
| CN110003066B (zh) * | 2013-11-18 | 2021-09-03 | 阿克丘勒斯治疗公司 | 用于rna递送的可电离的阳离子脂质 |
| US10426737B2 (en) * | 2013-12-19 | 2019-10-01 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| CN106794141B (zh) * | 2014-07-16 | 2021-05-28 | 诺华股份有限公司 | 将核酸包封在脂质纳米粒主体中的方法 |
| WO2020219876A1 (en) * | 2019-04-25 | 2020-10-29 | Intellia Therapeutics, Inc. | Ionizable amine lipids and lipid nanoparticles |
| EP4008741A4 (en) * | 2019-08-02 | 2023-06-28 | Daikin Industries, Ltd. | Fluorine-containing isocyanul compound |
-
2023
- 2023-04-05 EP EP23785347.8A patent/EP4504694A4/en active Pending
- 2023-04-05 CN CN202380032174.3A patent/CN119013250A/zh active Pending
- 2023-04-05 KR KR1020247036887A patent/KR20250009428A/ko active Pending
- 2023-04-05 AU AU2023249179A patent/AU2023249179A1/en active Pending
- 2023-04-05 WO PCT/US2023/017647 patent/WO2023196444A1/en not_active Ceased
- 2023-04-05 JP JP2024559484A patent/JP2025511899A/ja active Pending
- 2023-04-05 US US18/296,363 patent/US20230320995A1/en not_active Abandoned
- 2023-04-05 CA CA3254658A patent/CA3254658A1/en active Pending
- 2023-04-05 IL IL315577A patent/IL315577A/en unknown
-
2024
- 2024-03-20 US US18/610,897 patent/US20240299311A1/en not_active Abandoned
- 2024-10-02 MX MX2024012161A patent/MX2024012161A/es unknown